Shenkang injection ameliorates peritoneal fibrosis via the ESR1/PI3K/Akt pathway: Experimental verification and network pharmacology analysis

The International Journal of Biochemistry & Cell Biology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles